IDEAL MEDICAL PRODUCTS ENGINEERING : revenue, balance sheet and financial ratios

IDEAL MEDICAL PRODUCTS ENGINEERING is a French company founded 18 years ago, specialized in the sector Ingénierie, études techniques. Based in HOUILLES (78800), this company of category PME shows in 2021 a revenue of 1.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - IDEAL MEDICAL PRODUCTS ENGINEERING (SIREN 500999396)
Indicator 2021 2020 2019 2018 2016
Revenue 1 587 856 € 4 034 408 € 3 151 286 € 2 214 195 € 7 427 214 €
Net income -1 369 253 € -697 286 € 734 723 € 14 637 € 183 770 €
EBITDA 26 634 € -539 065 € 812 270 € 122 646 € -602 378 €
Net margin -86.2% -17.3% 23.3% 0.7% 2.5%

Revenue and income statement

In 2021, IDEAL MEDICAL PRODUCTS ENGINEERING achieves revenue of 1.6 M€. Revenue is declining over the period 2016-2021 (CAGR: -26.5%). Significant drop of -61% vs 2020. After deducting consumption (2 k€), gross margin stands at 1.6 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 27 k€, representing 1.7% of revenue. Positive scissor effect: EBITDA margin improves by +15.0 pts, sign of improved operational efficiency. The operating margin remains fragile, requiring cost vigilance. Net income is negative at -1.4 M€ (-86.2% of revenue), which will impact equity.

Revenue (2021) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

1 587 856 €

Gross margin (2021) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

1 586 021 €

EBITDA (2021) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

26 634 €

EBIT (2021) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

25 518 €

Net income (2021) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-1 369 253 €

EBITDA margin (2021) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

1.7%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 61%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Cash flow represents 2.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.

Debt ratio (2021) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.02%

Financial autonomy (2021) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

60.999%

Cash flow / Revenue (2021) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

2.186%

Repayment capacity (2021) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.0

Asset age ratio (2021) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

13.9%

Solvency indicators evolution
IDEAL MEDICAL PRODUCTS ENGINEERING

Sector positioning

Debt ratio
0.02 2021
2019
2020
2021
Q1: 0.0
Med: 11.41
Q3: 66.26
Excellent -25 pts over 3 years

In 2021, the debt ratio of IDEAL MEDICAL PRODUCTS EN... (0.02) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
61.0% 2021
2019
2020
2021
Q1: 10.94%
Med: 35.08%
Q3: 59.7%
Excellent

In 2021, the financial autonomy of IDEAL MEDICAL PRODUCTS EN... (61.0%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.0 years 2021
2019
2020
2021
Q1: 0.0 years
Med: 0.0 years
Q3: 1.32 years
Excellent -47 pts over 3 years

In 2021, the repayment capacity of IDEAL MEDICAL PRODUCTS EN... (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 172.22. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 5.2x. Operating income very largely covers interest expenses: high safety margin.

Liquidity ratio (2021) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

172.216

Interest coverage (2021) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

5.174

Liquidity indicators evolution
IDEAL MEDICAL PRODUCTS ENGINEERING

Sector positioning

Liquidity ratio
172.22 2021
2019
2020
2021
Q1: 151.29
Med: 231.51
Q3: 390.77
Average -17 pts over 3 years

In 2021, the liquidity ratio of IDEAL MEDICAL PRODUCTS EN... (172.22) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
5.17x 2021
2019
2020
2021
Q1: 0.0x
Med: 0.0x
Q3: 1.05x
Excellent

In 2021, the interest coverage of IDEAL MEDICAL PRODUCTS EN... (5.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 1568 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 144 days. The gap of 1424 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 568 days of revenue, i.e. 2.5 M€ to permanently finance. Notable WCR improvement over the period (-53%), freeing up cash.

Operating WCR (2021) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

2 506 240 €

Customer credit (2021) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

1568 j

Supplier credit (2021) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

144 j

Inventory turnover (2021) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2021) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

568 j

WCR and payment terms evolution
IDEAL MEDICAL PRODUCTS ENGINEERING

Positioning of IDEAL MEDICAL PRODUCTS ENGINEERING in its sector

Comparison with sector Ingénierie, études techniques

Valuation estimate

Based on 52 transactions of similar company sales in 2021, the value of IDEAL MEDICAL PRODUCTS ENGINEERING is estimated at 269 683 € (range 141 888€ - 363 986€). With an EBITDA of 26 634€, the sector multiple of 0.5x is applied. The price/revenue ratio is 0.44x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2021
52 tx
141k€ 269k€ 363k€
269 683 € Range: 141 888€ - 363 986€
NAF 5 année 2021

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
26 634 € × 0.5x
Estimation 13 983 €
13 475€ - 38 467€
Revenue Multiple 30%
1 587 856 € × 0.44x
Estimation 695 850 €
355 911€ - 906 518€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 52 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Ingénierie, études techniques)

Compare IDEAL MEDICAL PRODUCTS ENGINEERING with other companies in the same sector:

Voir toutes les statistiques du secteur Ingénierie, études techniques

Frequently asked questions about IDEAL MEDICAL PRODUCTS ENGINEERING

What is the revenue of IDEAL MEDICAL PRODUCTS ENGINEERING ?

The revenue of IDEAL MEDICAL PRODUCTS ENGINEERING in 2021 is 1.6 M€.

Is IDEAL MEDICAL PRODUCTS ENGINEERING profitable?

IDEAL MEDICAL PRODUCTS ENGINEERING recorded a net loss in 2021.

Where is the headquarters of IDEAL MEDICAL PRODUCTS ENGINEERING ?

The headquarters of IDEAL MEDICAL PRODUCTS ENGINEERING is located in HOUILLES (78800), in the department Yvelines.

Where to find the tax return of IDEAL MEDICAL PRODUCTS ENGINEERING ?

The tax return of IDEAL MEDICAL PRODUCTS ENGINEERING is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does IDEAL MEDICAL PRODUCTS ENGINEERING operate?

IDEAL MEDICAL PRODUCTS ENGINEERING operates in the sector Ingénierie, études techniques (NAF code 71.12B). See the 'Sector positioning' section above to compare the company with its competitors.